Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heike Claus

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
Antimicrobial Agents and Chemotherapy|July 8, 2010
Multicenter study for defining the breakpoint for rifampin resistance in Neisseria meningitidis by rpoB sequencingMuhamed-Kheir Taha, Sara Thulin Hedberg, Marek Szatanik, et al.
The Journal of Antimicrobial Chemotherapy|July 20, 2023
CHROMAgar™ LIN-R as an efficient screening tool to assess the prevalence of linezolid-resistant enterococci in German hospital patients-a multicentre study approach, 2021-2022Jennifer K Bender, Elsa Baufeld, Karsten Becker, et al.
Mbio|March 15, 2018
Predicting the Susceptibility of Meningococcal Serogroup B Isolates to Bactericidal Antibodies Elicited by Bivalent rLP2086, a Novel Prophylactic VaccineLisa K McNeil, Robert G K Donald, Alexey Gribenko, et al.
Clinical and Vaccine Immunology : CVI|April 4, 2014
Implications of differential age distribution of disease-associated meningococcal lineages for vaccine developmentCarina Brehony, Caroline L Trotter, Mary E Ramsay, et al.
The Lancet. Infectious Diseases|February 19, 2013
Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessmentUlrich Vogel, Muhamed-Kheir Taha, Julio A Vazquez, et al.
Clinical and Vaccine Immunology : CVI|August 10, 2012
Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccinesBrian D Plikaytis, Maria Stella, Giuseppe Boccadifuoco, et al.
The Journal of Infection|July 23, 2025
Umrah- and travel-associated meningococcal disease due to multiple serogroup W ST-11 sub-strains pre-Hajj 2024Jay Lucidarme, Ala-Eddine Deghmane, Shalabh Sharma, et al.
Infection|February 17, 2024
Outbreak of severe community-acquired bacterial infections among children in North Rhine-Westphalia (Germany), October to December 2022Sarah C Goretzki, Mark van der Linden, Andreas Itzek, et al.
The Lancet. Digital Health|December 21, 2024
The importance of microbiology reference laboratories and adequate funding for infectious disease surveillanceDavid Shaw, Raquel Abad Torreblanca, Zahin Amin-Chowdhury, et al.
The Lancet. Digital Health|July 29, 2023
Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS ConsortiumDavid Shaw, Raquel Abad, Zahin Amin-Chowdhury, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Antimicrobial Agents and Chemotherapy|July 8, 2010
Multicenter study for defining the breakpoint for rifampin resistance in Neisseria meningitidis by rpoB sequencingMuhamed-Kheir Taha, Sara Thulin Hedberg, Marek Szatanik, et al.
The Journal of Antimicrobial Chemotherapy|July 20, 2023
CHROMAgar™ LIN-R as an efficient screening tool to assess the prevalence of linezolid-resistant enterococci in German hospital patients-a multicentre study approach, 2021-2022Jennifer K Bender, Elsa Baufeld, Karsten Becker, et al.
Mbio|March 15, 2018
Predicting the Susceptibility of Meningococcal Serogroup B Isolates to Bactericidal Antibodies Elicited by Bivalent rLP2086, a Novel Prophylactic VaccineLisa K McNeil, Robert G K Donald, Alexey Gribenko, et al.
Clinical and Vaccine Immunology : CVI|April 4, 2014
Implications of differential age distribution of disease-associated meningococcal lineages for vaccine developmentCarina Brehony, Caroline L Trotter, Mary E Ramsay, et al.
The Lancet. Infectious Diseases|February 19, 2013
Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessmentUlrich Vogel, Muhamed-Kheir Taha, Julio A Vazquez, et al.
Clinical and Vaccine Immunology : CVI|August 10, 2012
Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccinesBrian D Plikaytis, Maria Stella, Giuseppe Boccadifuoco, et al.
The Journal of Infection|July 23, 2025
Umrah- and travel-associated meningococcal disease due to multiple serogroup W ST-11 sub-strains pre-Hajj 2024Jay Lucidarme, Ala-Eddine Deghmane, Shalabh Sharma, et al.
Infection|February 17, 2024
Outbreak of severe community-acquired bacterial infections among children in North Rhine-Westphalia (Germany), October to December 2022Sarah C Goretzki, Mark van der Linden, Andreas Itzek, et al.
The Lancet. Digital Health|December 21, 2024
The importance of microbiology reference laboratories and adequate funding for infectious disease surveillanceDavid Shaw, Raquel Abad Torreblanca, Zahin Amin-Chowdhury, et al.
The Lancet. Digital Health|July 29, 2023
Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS ConsortiumDavid Shaw, Raquel Abad, Zahin Amin-Chowdhury, et al.
Pageof 13